The open index of psychedelic research

Open datasets, papers, preregistrations, and trials from across psychedelic science.

11,281 records6 sources
Showing 793–816 of 11,281
ArticlePsilocybin

Serotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networks.

Gudmundsen F, Czurylo J, Rijsketic DR +10

Europe PMC2026
TrialPsilocybin

Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

ClinicalTrials.gov2026
ArticleKetamine

A crucial cautionary note on frequently incorrect dose equivalence between ketamine and esketamine.

Damiano RF, Medeiros GC, Quevedo J

Europe PMC2026
ArticleKetamine

Comparison of xylazine-ketamine-guaifenesin and xylazine-tiletamine-zolazepam protocols for constant rate infusion anesthesia in horses undergoing field castration.

Maneephan P, Thepparat K, Suwanekkasit B +5

Europe PMC2026
ArticleKetamine

Esketamine versus dexmedetomidine for oxygenation and postoperative quality of recovery in thoracoscopic surgery: a randomized, double-blind, non-inferiority controlled trial.

Feng R, Wang Z, Yang Y +4

Europe PMC2026
ArticlePsychedelics

Molecules, meaning, and physiology: disentangling the active ingredients of psychedelic therapeutics.

Kuypers KPC

Europe PMC2026
ArticlePsychedelics

Detection of drugs of abuse: evolving analytical strategies and emerging challenges.

Eliw N, Alhefeiti MA, Shamroukh AA +1

Europe PMC2026
PreprintPsychedelics

Clinical Approaches to Non-Ordinary Experiences (NOEs): scoping review and bibliometric analysis

de Oliveira Maraldi E, Cafezeiro AS, da Silva TO +14

Europe PMC2026
ArticlePsilocybin

Efficacy and risks of psychedelics in the treatment of posttraumatic stress disorder: A systematic review.

Thomas JE, Dellarole A, Caballero J

Europe PMC2026
ArticleDMT

Inhalable Psychedelic 5-MeO-DMT Shows Promise in Treatment-Resistant Depression.

Ali S, Tian X, Anastasio NC +2

Europe PMC2026
TrialDMT

Inhaled DMT for Major Depressive Disorder

ClinicalTrials.gov2026
ArticleDMT

Proliferative Effects of the Psychedelic N,N-Dimethyltryptamine (DMT) in Human Neural Stem Cells.

Salerno JA, Dominguez ER, Karmirian K +7

Europe PMC2026
TrialKetamine

Dexmedetomidine-Esketamine Combination on Depression and Anxiety After Laparoscopic Ureteral Reconstruction

ClinicalTrials.gov2026
ArticlePsilocybin

Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs.

Ippolito A, Tiranti A, Hurley S +3

Europe PMC2026
TrialPsilocybin

Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder

ClinicalTrials.gov2026
TrialKetamine

Intraperitoneal Ketamine Versus Fentanyl as Adjuvants to Bupivacaine in Laparoscopic Cholecystectomy

ClinicalTrials.gov2026
ArticleKetamine

The Safety and Feasibility of Oral Aspirin and Ketamine for Acute Pain Management After Total Knee Arthroplasty: A Pilot Study.

Devine DK, Grubel J, Haas SB +7

Europe PMC2026
ArticleKetamine

Esketamine during anesthesia induction improves early postoperative sleep quality in female patients undergoing laparoscopic surgery: A randomized trial.

Du R, Fei G, Zhang J +1

Europe PMC2026
TrialKetamine

Comparing Esketamine and Remazolam With Propofol for Breathing Safety in Pediatric Gastroscopy

ClinicalTrials.gov2026
TrialKetamine

Low Dose Bolus Ketamine For Use In Sickle Cell Pain Crisis

ClinicalTrials.gov2026
TrialPsilocybin

Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS)

ClinicalTrials.gov2026
ArticlePsilocybin

The mechanism debate in psilocybin therapy for depression.

eBioMedicine

Europe PMC2026
ArticleLSD

LSD therapy: A few hundred meters from where it began.

Müller F, Becker AM, Böhlke C +2

Europe PMC2026
ArticleKetamine

Dose-dependent effect of esketamine on preventing rocuronium-induced limb withdrawal in preschool children.

Wang J, Zhou Z, Ma WL

Europe PMC2026